Alpha Synuclein: Aggregation

The characteristic feature of protein misfolding diseases is “the deposition of insoluble protein aggregates and amyloid fibrils caused by accumulation of homogenous proteins which are abnormally folded into B-sheet structures” (Roostaee et al., 2013). The process of α-synuclein aggregation starts when monomers accumulate into oligomeric intermediates, followed by the formation of amyloid fibers which cluster into disease specific inclusions (Winner et al., 2011). Roostaee et al. (2013) concluded that a dimeric state exists in the conversion of α-synuclein monomers to oligomers suggesting that dimerization is the main mechanism initiating protein aggregation.

In the process of α-synuclein fibrilization, certain solvent conditions can produce specific types of morphology. Elements that promote fibrilization are higher salt concentration and temperature, and an acidic pH (Sidhu et al., 2014)

Scientists have proposed that either amyloid-like insoluble fibrils or soluble prefibrillar intermediates (oligomers and protofibrils) are the toxic species in PD (Dehay et al., 2015). Winner et al. (2011) created α-synuclein mutants that increased either the oligomer or fibril formation in a rat lentivirus system and tested the toxicity by analyzing loss of dopamine producing neurons in the substantia nigra. Their results showed that the α-synuclein oligomers promote higher levels of toxicity than the α-synuclein fibrils, making oligomers the toxic species in PD.

Both endogenous and exogenous α-synuclein participates to induce aggregation and fibrilization. Exogenous α-synuclein preformed fibrils enter the neurons, most likely by absorptive mediated endocytosis, and mediate the recruitment of soluble endogenous α-synuclein into LBs and LNs (Volpicelli-Daley et al., 2011). The exogenous preformed α-synuclein fibrils seed aggregation inside the cell, as monomeric α-synuclein is not sufficient alone. The α-synuclein gathered into pathogenic inclusions is phosphorylation at pSer129 and ubiquitinated intracellularly.

Endogenous aggregation is ordinarily limited by the amount of active nucleation sites present in the cytoplasm, however, exogenous α-synuclein solves this dilemma (Luk et al., 2009). The exogenous preformed α-synuclein fibrils act as the “seed” for aggregation by binding to the plasma membrane and becoming nucleation sites for the formation of α-synuclein fibrils. Binding to the plasma membrane promotes the accumulation and internalization of α-synuclein aggregates and turns on the extrinsic and intrinsic apoptotic cell death pathways (Mahul-Mellier et al., 2015). In conclusion, LB and LN formation can be initiated by misfolded proteins, and then propagated in the neuronal cells by exogenous α-synuclein seeding.